Home

Helius Medical Technologies, Inc. - Class A Common Stock (HSDT)

1.0900
+0.00 (0.00%)
NASDAQ · Last Trade: Jun 9th, 9:39 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close1.090
Open-
Bid0.8704
Ask0.8800
Day's RangeN/A - N/A
52 Week Range0.8008 - 24.00
Volume1,330,839
Market Cap4.06M
PE Ratio (TTM)-0.3449
EPS (TTM)-3.2
Dividend & YieldN/A (N/A)
1 Month Average Volume2,292,163

Chart

About Helius Medical Technologies, Inc. - Class A Common Stock (HSDT)

Helius Medical Technologies is focused on developing and commercializing innovative medical devices aimed at improving treatment options for patients with neurological conditions, particularly those suffering from disorders resulting from traumatic brain injuries. The company's flagship product is designed to enhance the brain's natural ability to heal itself by leveraging neurotechnology. Helius is committed to advancing the field of neurology through rigorous scientific research and collaborations, ultimately aiming to improve outcomes and quality of life for affected individuals. Read More

News & Press Releases

Why Circle Internet Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · June 9, 2025
Get insights into the top gainers and losers of Monday's pre-market session.chartmill.com
As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Via Chartmill · June 9, 2025
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · June 9, 2025
How Is The Market Feeling About Helius Medical Tech?benzinga.com
Via Benzinga · January 22, 2025
The trading volume of these stocks is deviating from the norm in today's session.chartmill.com
Unusual volume stocks in Friday's session
Via Chartmill · June 6, 2025
Discover the top movers in Friday's pre-market session.chartmill.com
Discover the top movers in Friday's pre-market session and stay informed about market dynamics.
Via Chartmill · June 6, 2025
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · June 6, 2025
Why Rent the Runway Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · June 6, 2025
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · June 5, 2025
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · June 5, 2025
Why MongoDB Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · June 5, 2025
Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering
NEWTOWN, Pa., June 04, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced the pricing of its public offering of an aggregate of 2,768,600 shares of its Class A common stock (or common stock equivalents), and warrants to purchase up to 2,768,600 shares of common stock, at a combined public offering price of $3.27 per share and accompanying warrants.
Helius Medical Technologies, Inc. Compliant with Nasdaq Bid Price Rule Listing Criteria
Company previously granted extension until June 30, 2025 to regain compliance with Nasdaq’s Equity Rule requirement
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · May 22, 2025
Helius to Spotlight Study Confirming Improved Long-Term Outcomes from Adherence to PoNS Therapy® at CMSC Annual Meeting
Shepherd Center’s Dr. Deborah Backus to Showcase Final Results of PoNSTEP Study, Providing New Insight into Maximizing Impact of Neuromodulation to Improve Gait in People with MS
Helius Medical Technologies, Inc. Announces Reimbursement by Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device
United Healthcare approves claim for PoNS Device at out-of-network adjusted list price, becoming the second payer to join Anthem in providing PoNS reimbursement
Helius Medical Technologies Announces Reverse Stock Split
NEWTOWN, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, announced today a 1-for-15 reverse split of its Class A common stock, par value $0.001 (“common stock”), effective at 5:00 pm Eastern time on May 1, 2025. Beginning on May 2, 2025, the Company’s common stock will trade on The Nasdaq Capital Market on a split adjusted basis.
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · March 24, 2025
Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface (“BCI”) Technology Private Subsidiary
--Revelation Neuro, Inc. is focused on advancing development of a Non-Implantable Artificial Intelligence (“AI”) Powered BCI Technology--
Helius Medical Technologies, Inc. Announces First Reimbursement by A Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device
--Anthem Blue Cross Blue Shield approves claim for PoNS Device at out-of-network adjusted list price--
Helius Medical Technologies, Inc. (NASDAQ: HSDT) Featured in Coverage of the 37th Annual ROTH Conference
Helius Medical Technologies (NASDAQ: HSDT) is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. The company’s first commercial product is the Portable Neuromodulation Stimulator. For more information about the PoNS® or Helius Medical Technologies, visit www.heliusmedical.com.
Via Investor Brand Network · March 10, 2025
Tuesday's after hours session: top gainers and loserschartmill.com
Discover the top movers in Tuesday's after-hours session and stay informed about the post-market dynamics.
Via Chartmill · March 4, 2025
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · February 7, 2025
Why Pinterest Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · February 7, 2025
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · January 22, 2025